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ABSTRACT Clostridioides difficile is a major cause of diarrhea associated with antibio-
therapy. After germination of C. difficile spores in the small intestine, vegetative cells are
exposed to low oxygen (O2) tensions. While considered strictly anaerobic, C. difficile is
able to grow in nonstrict anaerobic conditions (1 to 3% O2) and tolerates brief air expo-
sure indicating that this bacterium harbors an arsenal of proteins involved in O2 detoxifi-
cation and/or protection. Tolerance of C. difficile to low O2 tensions requires the pres-
ence of the alternative sigma factor, B, involved in the general stress response. Among
the genes positively controlled by B, four encode proteins likely involved in O2 detoxifi-
cation: two flavodiiron proteins (FdpA and FdpF) and two reverse rubrerythrins (revRbr1
and revRbr2). As previously observed for FdpF, we showed that both purified revRbr1
and revRbr2 harbor NADH-linked O2- and H2O2-reductase activities in vitro, while puri-
fied FdpA mainly acts as an O2-reductase. The growth of a fdpA mutant is affected at
0.4% O2, while inactivation of both revRbrs leads to a growth defect above 0.1% O2. O2-
reductase activities of these different proteins are additive since the quadruple mutant
displays a stronger phenotype when exposed to low O2 tensions compared to the triple
mutants. Our results demonstrate a key role for revRbrs, FdpF, and FdpA proteins in the
ability of C. difficile to grow in the presence of physiological O2 tensions such as those
encountered in the colon.
IMPORTANCE Although the gastrointestinal tract is regarded as mainly anoxic, low O2
tension is present in the gut and tends to increase following antibiotic-induced disrup-
tion of the host microbiota. Two decreasing O2 gradients are observed, a longitudinal
one from the small to the large intestine and a second one from the intestinal epithe-
lium toward the colon lumen. Thus, O2 concentration fluctuations within the gastrointes-
tinal tract are a challenge for anaerobic bacteria such as C. difficile. This enteropathogen
has developed efficient strategies to detoxify O2. In this work, we identified reverse
rubrerythrins and flavodiiron proteins as key actors for O2 tolerance in C. difficile. These
enzymes are responsible for the reduction of O2 protecting C. difficile vegetative cells
from associated damages. Original and complex detoxification pathways involving O2-
reductases are crucial in the ability of C. difficile to tolerate O2 and survive to O2 concen-
trations encountered in the gastrointestinal tract.
KEYWORDS oxygen reductase, peroxide reductase, oxygen tolerance, anaerobes,
stress response, sigmab
Clostridioides difficile (formerly Clostridium difficile) is a spore-forming and anaerobicGram-positive bacterium. C. difficile’s aeroresistant and metabolically dormant
spores are ubiquitous in the environment and are commonly found on hospital surfaces
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and in the mammalian gastrointestinal tract (1). Nowadays, this pathogen is considered
the major cause of antibiotic-associated diarrhea and pseudomembranous colitis (2). C.
difficile infection (CDI) is transmitted via the oral-fecal route (3) through ingestion of
spores, the form for the transmission, resistance, and persistence of this bacterium (4).
Colonization of the gastrointestinal tract usually occurs following antibiotic-induced
dysbiosis of the host microbiota, which leads to substantial changes in the metabolic
pool, particularly in bile acids (5). These metabolic modifications enable germination of
the spores in the small intestine and thereafter colonization of the intestinal tract by the
vegetative cells (6). Then, C. difficile cells produce virulence factors, including two toxins,
TcdA and TcdB, that cause the pathology associated with CDI. These toxins are
responsible for alteration of the actin cytoskeleton of intestinal epithelial cells, which
induces intestinal cell lysis and triggers an important inflammation (7, 8). The inflam-
mation process results in the production by the host immune system of reactive oxygen
species (ROS), nitric oxide (NO), and reactive nitrogen species (RNS) at bactericidal
concentrations (9, 10).
Apart from inflammation-induced oxidative and nitrosative stresses, oxygen (O2) is
also a major stress that C. difficile faces during gut colonization. Indeed, although a
healthy gut, with a diverse microbiota, is regarded as mainly anoxic, a longitudinal
decreasing O2 gradient is observed along the gastrointestinal tract (11). From 4% in the
small intestine lumen, which is the location of spore germination, the O2 tension
decreases to 0.1 to 0.4% in the large intestine lumen, where vegetative cells multiply
(11). A second increasing O2 gradient from the colon lumen toward the intestinal
epithelium also occurs (from 0.1 to 0.4% to 5%) (12, 13). In addition, antibiotic-induced
disruption of the host microbiota leads to an increased O2 level within the gut (12, 14).
Thus, O2 concentration fluctuations within the gastrointestinal tract present a challenge
to anaerobic bacteria such as C. difficile. While strictly anaerobic, C. difficile is able to
grow in nonstrict anoxic conditions (1 to 3% O2) (15), indicating that this bacterium
encodes an arsenal of proteins involved in O2 detoxification and protection against
oxidative stress. Recently, the deletion of the iscS2 gene encoding a cysteine desul-
furase likely involved in Fe-S cluster biogenesis was shown to cause a severe growth
defect in the presence of 2% O2 (16). Another essential actor in the C. difficile ability to
tolerate low O2 concentrations is the alternative sigma factor involved in the general
stress response, B. Indeed, a sigB mutant is unable to grow in the presence of 0.1% O2,
a tension lower than that physiologically found in the large intestine (17). Of note, both
sigB and iscS2 mutants present a colonization defect in axenic mice, and a delay of
colonization is observed for the iscS2 mutant in conventional mice (17). These results
suggest that O2 tolerance might be an important mechanism during the C. difficile
colonization process. However, little is known about the proteins involved in the ability
of C. difficile to tolerate O2.
In other organisms, both flavodiiron proteins (FDPs) and rubrerythrins (Rbrs) play an
important role in protecting the cells from O2, oxidative, or nitrosative stresses (18–21).
FDPs are enzymes composed of a minimal core containing a diiron catalytic center in
a metallo--lactamase-like domain and a flavin-mononucleotide (FMN)-containing fla-
vodoxin domain, located at the N- and C-terminal ends, respectively, of the protein
(22–24). FDPs reduce oxygen to water or NO to nitrous oxide. Although some of these
enzymes show substrate specificity toward O2 or NO, others have a dual activity.
Canonical Rbrs are composed by two types of iron sites: an N-terminal four-helix
bundle domain harboring a non-sulfur diiron center and a rubredoxin (Rd)-like [Fe(S-
Cys)4] domain in the C-terminal part (25, 26). In reverse Rbrs (revRbrs), the position of
these two domains are reversed. Rbrs act as peroxidases through NAD(P)H oxidation in
partnership with another redox partner, and O2-reductase activity has also been
reported for a revRbr from Clostridium acetobutylicum (20, 25, 27, 28). Both FDPs and
Rbrs are broadly distributed among anaerobic and microaerophilic bacteria and ar-
chaea, but they are also present in aerobes and in eukaryotes. Most FDPs, as well as
Rbrs and revRbrs, require electron transfer proteins as physiological partners to couple
the oxidation of NAD(P)H to the reduction of their substrates, such as rubredoxins (Rds),
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NAD(P)H/FAD dependent oxidoreductases or the F420 coenzyme in methanogens (20,
29–32).
The genome of C. difficile harbors genes encoding two FDPs (CD1157 and CD1623,
here named FdpA and FdpF, respectively, according to their domain composition [24]),
two Rbrs (CD0825 and CD2845) and two revRbrs (CD1474 and CD1524, here named
revRbr1 and revRbr2, respectively). While CD2845 is expressed under the control of G
(33) and its product is present in the spore (34), the expression of CD0825, revRbr1,
revRbr2, fdpA, and fdpF is positively controlled by B (17). Among the six aforemen-
tioned proteins, only FdpF is functionally characterized (35). FdpF is a large class F FDP
(24) that harbors, in addition to the minimal core universally present in FDPs, two other
domains: a Rd domain of the short type, which distinguishes from canonical Rds by its
smaller number of amino acids in between the two pairs of iron-binding cysteines (12
amino acids versus 30 amino acids) (36) and a NAD(P)H:Rd oxidoreductase-like
domain (NROR) (see Fig. S1 in the supplemental material). This protein acts mainly as
an NADH:O2 oxidoreductase reducing O2 to H2O but also exhibits a detectable H2O2
reductase activity (35). Due to the presence in the same polypeptide chain of the extra
domains, FdpF receives electrons directly from NADH and transfers them to O2 without
the participation of additional protein partners (35). In the present study, we demon-
strate a key role for both FDPs and both revRbrs, whose genes are controlled by B,
in the ability of C. difficile to tolerate physiological O2 tensions encountered within
the gut.
RESULTS
Regulation of revRbr1, revRbr2, fdpF, and fdpA expression. Genome-wide tran-
scriptional start site (TSS) mapping allowed us to identify promoters upstream of
CD0825, revRbr1 (CD1474), revRbr2 (CD1524), fdpA (CD1157), and fdpF (CD1623) (37). A
B consensus sequence [WGWTT-N13-17-(G/T)GGTAWA] was identified upstream of the
TSSs mapped in the promoter region of revRbr1, revRbr2, fdpF, and fdpA genes (Fig. 1A
to C) (17). In contrast, a canonical 10 box (TATACT) and a 35 box (TTGACA) of a
A-dependent promoter were identified upstream of the CD0825 mapped TSS (Fig. 1D),
suggesting indirect control by B, in agreement with the weaker transcriptional control
by B observed for this gene compared to the others (17). Interestingly, upstream of the
B-dependent promoter of the fdpA gene, a second TSS was mapped corresponding to
a promoter with a canonical extended 10 box (TGNTATATT) of a A-dependent
promoter and a poorly conserved 35 box, as often observed with a 10 extended box
(Fig. 1C).
We next focused on the genes harboring a B consensus sequence in their promoter
region, and we wanted to determine whether their expression was strictly dependent
on B. Using transcriptional fusions between the promoter regions of the revRbr2 and
fdpF genes and the gene encoding the fluorescent reporter SNAPCd (38), we detected
expression of the PrevRbr2- and PfdpF-SNAPCd fusions in the wild-type (WT) strain in 77
and 61% of the cells, respectively, after 16 h of growth. In contrast, the expression of
both fusions was completely abolished in the sigB mutant as observed for the revRbr1
gene (Fig. 1E and F) (39). To study the more complex expression of the fdpA gene from
its two promoters, we first constructed a transcriptional fusion between SNAPCd and the
two promoters. Expression of the PA/B(fdpA)-SNAPCd fusion was detected in 12% of the
cells in the WT strain (Fig. 1G). Contrary to the PrevRbr2- and PfdpF-SNAPCd fusions,
expression of the PA/B(fdpA)-SNAPCd fusion in the sigB mutant was still detected in a
small fraction of the cells in agreement with the existence of the A-dependent
promoter (Fig. 1G). When we monitored the expression of a PB(fdpA)-SNAPCd fusion
containing only the B-dependent promoter, we detected fluorescent cells in the WT
strain but not in the sigB mutant, confirming that this promoter is recognized by B
(Fig. 1H). Thus, the fdpA expression is dependent on both A and B, while the
expression of revRbr2 and fdpF is only B dependent in C. difficile, as observed for
revRbr1 (39).
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FDPs and revRbrs of C. difficile. FdpA (397 amino acids) is a class A FDP (see
Fig. S1A in the supplemental material) harboring only the minimal core common to all
FDPs (24). The sequence alignment of both FdpA and FdpF cores (diiron and FMN
domains) against the structural alignment of all FDPs with available structures (see
Fig. S2A) reveals that the sequence identity between the core domains of FdpA and
FdpF is only 29%. Despite this relatively low identity percentage, the structural align-
ment shows that the most conserved regions of characterized FDPs are also present in
both FdpA and FdpF. The predicted amino acids involved in the coordination of the
diiron center in FdpA are histidines (His80, His85, His146, and His224), aspartates (Asp84
and Asp165), and one glutamate (Glu82) (see Fig. S2A) (35). The sequence alignment also
reveals a significant conservation of other features, such as the putative chain of
aromatic amino acids (22) formed by Tyr191, Tyr192, Tyr239, and Trp242.
RevRbr1 and revRbr2 share 96% amino acid identity among themselves (Fig. S1B).
However, only ca. 25% identity is observed with other rubrerythrins, when a sequence
FIG 1 Transcriptional control of revRbr2, fdpF, and fdpA. The promoter regions of revRbr2 (A), fdpF (B), fdpA (C), and CD0825 (D) genes
are shown. The mapped transcriptional start sites (1) located at positions 1766842 (revRbr2), 1878917 (fdpF), 1356839 and 1356915
(fdpA), and 1000259 (CD0825) are represented in red uppercase. The 10 and 35 promoter elements corresponding to the consensus
for promoters recognized by A or B are indicated in boldface and highlighted in blue and red, respectively (37). The possible RBS
and start codon of revRbr1, fdpF, fdpA, and CD0825 are highlighted in blue and green, respectively. Microscopy analysis of C. difficile
cells carrying PrevRbr2-SNAPCd (E), PfdpF-SNAPCd (F), PA/B(fdpA)-SNAPCd (G), and PB(fdpA)-SNAPCd (H) transcriptional fusions in the 630Δerm
strain and in the sigB mutant was performed. The strains were grown 16 h in BHI. The merged images show the overlap between the
TMR-Star (red) and the autofluorescence (AF; green) channels. About 200 cells were scored for each strain and the numbers represent
the percentage of cells with signal. These data are representative of two independent experiments. Scale bar, 1 m.
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alignment of the four-helix bundle domain of these two revRbrs is performed against
a structural alignment of the four-helix bundle domain of three canonical rubrerythrins
with known structures (see Fig. S2B). The major predicted difference occurs in the loop
connecting the two pairs of helices, which is shorter in revRbrs. Contrary to what was
observed for the C. difficile FDPs, there is no significative conservation of large protein
regions apart from the diiron center ligands (see Fig. S2B), which are predicted to be
glutamates (Glu67 and Glu130) and histidines (His70 and His133, revRbr1 numbering) (26).
The Rd domain contains two CysXXCys motifs (Cys6/Cys9 and Cys22/Cys25) separated by
12 residues (see Fig. S1B), which is typical of short-spaced Rd domains found in most
Rbrs, as well as in the Rd domains of several classes of FDPs, including FdpF (24, 35, 36).
Proteins characterization and redox properties. To characterize their properties
and functions, the FdpA, revRbr1, and revRbr2 proteins were overexpressed in Esche-
richia coli and purified through several chromatographic steps in a process analogous
to those previously used for similar proteins (32, 40–46). The molecular masses deter-
mined by SDS-PAGE were 45 kDa for FdpA and 22 kDa for the two revRbrs, in
agreement with those calculated from their respective amino acid sequences, 44.8 and
20 kDa, respectively (see Fig. S3A). Size exclusion chromatography of the purified
proteins revealed that FdpA is a homodimer in solution, with a molecular mass of
82 kDa, while both revRbrs are isolated as tetramers with molecular masses of
90 kDa (see Fig. S3B). The presence of homodimers and homotetramers in solution is
typical of other FDPs and Rbrs (23, 47, 48). For FDPs, the homodimer organization is
essential for efficient electron transfer between the electron accepting site in one
monomer, the FMN, and the diiron center of the other monomer.
For FdpA, quantification of iron and flavin yielded iron/FMN/protein monomer ratios
of 1/0.3/1. These values are lower than expected (i.e., 2/1/1), indicating an incomplete
incorporation of both iron and FMN. Even after incubation with FMN following purifi-
cation, no significant improvement was observed. For revRbr1 and revRbr2, the iron/
protein monomer ratios were 2.1/1 and 2.9/1, respectively, instead of the expected 3/1
ratio. Thus, while revRbr2 is almost fully loaded with iron, revRbr1 is only partially
loaded.
By reversed-phase high-pressure liquid chromatography, FMN was identified as the
FdpA flavin cofactor, as observed so far for all FDPs (22, 24). FdpA exhibited a UV-visible
absorbance spectrum typical of a flavin-containing protein, with maxima at 380 and
450 nm (see Fig. S4A). The UV-visible spectra of revRbr1 and revRbr2 were characteristic
of proteins containing a Rd center, with maxima at 380, 490, and 580 nm (see Fig. S4B
and C). For these three proteins, the spectral contribution of the diiron sites was not
detected due to their low molar absorptivities (49). Nevertheless, the diiron site of FdpA
was detected by electron paramagnetic resonance (EPR) upon partial reduction with
menadiol. As already observed for the E. coli FDP (50), the EPR spectrum revealed a
mixture of species, with g values of 1.69, 1.71, 1.98, 1.83, 1.84, and 1.93 (Fig. 2), typical
of S  1/2 anti-ferro-magnetically coupled diiron sites in the mixed valence form
[Fe(III)-Fe(II)]. For the revRbrs, we could only observe the typical resonances at g  4.3
and a minor resonance at g  9.3, attributable, respectively, to the middle (|3/2)
and lower (|1/2) doublets of a high-spin (S  5/2) ferric center, with a rhombicity
(E/D) close to 0.33, characteristic of the ferric [Fe(SCys)4] sites (51). Overall, the spec-
troscopic properties of FdpA and revRbrs are identical to those of analogs (42–44).
The reduction potential of the Rd center for both revRbrs was obtained by redox
titrations monitored by visible spectroscopy in an anaerobic chamber at pH 7.5,
following the decrease in absorbance of the ferric Rd site (see Fig. S5A and B). We
obtained values of 10 mV  5 mV and of 10 mV  5 mV for revRbr1 and revRbr2,
respectively, which are similar to those of previously isolated Rds (generally in the range
of 50 to 50 mV [reviewed in reference 51]) but significantly lower than those thus
far reported for the Rd centers of the few studied canonical rubrerythrins: 213 and
281 mV for the Desulfovibrio vulgaris nigerythrin and rubrerythrin, respectively, and
185 mV for the Campylobacter jejuni desulforubrerythrin (43, 47, 52). Interestingly, for
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the enzyme from C. jejuni, the desulforedoxin-like center has a high positive potential
(240 mV) (47), compared to other known desulforedoxin-like centers (0 mV). This
reinforces the idea that there is a very large variability in the reduction potentials of Rd
and Rd-like centers that remain to be assigned to specific features of the polypeptide
chains close to the metal center, in spite of its identical structure. The flavin center of
FdpA was titrated similarly, and the reduction potentials obtained were 60  15
and 175  15 mV for the FMNox/FMNsemiquinone and FMNsemiquinone/FMNred redox
transitions (see Fig. S5C), values within the range of those available for a few other
FDPs (24, 53).
revRbrs and FDP H2O2- and O2-reductase activities. Having established the
presence of the FMN and iron cofactors and determined the redox properties of FdpA,
revRbr1, and revRbr2, we addressed the catalytic activities of these proteins. The O2-
and H2O2-reductase activities of the three enzymes were determined using NADH as
the primary electron donor. As expected, FdpA, revRbr1, and revRbr2 alone did not
show any NADH oxidase activity (Fig. 3, before the addition of substrate). Since the C.
FIG 2 Electron paramagnetic resonance spectra of FdpA. Spectrum A corresponds to FdpA after
anaerobic incubation with one equivalent of menadiol. The two species observed in the experimental
spectrum were theoretically simulated (spectrum C with g  1.83, 1.84, and 1.93; spectrum D with
g  1.69, 1.71, and 1.98), and spectrum B corresponds to their sum at a 1:0.9 ratio. Temperature of 7 K,
microwave frequency of 9.41 GHz, modulation amplitude of 1.0 mT, and microwave frequency of 2 mW.
FIG 3 H2O2-reductase activity of revRbr1, revRbr2, and FdpA. The activities were determined anaerobically (at least five assays for each enzyme) by measuring
NADH consumption monitored at 340 nm. The data presented are representative of the results obtained. The protein concentrations in each assay were 2.5 M
for NROR, 2.5 M for the Rd-D, and 0.1 M for revRbr1 (A) and 0.03 M for revRbr2 (B). (C) In the assays where FdpA was tested, the protein concentrations
were 5 M for the NROR and the Rd-D and 1 M for FdpA. Experiments were performed in the presence of 200 M NADH and different H2O2 concentrations:
30 M and 90 M H2O2 were used for revRbr1 and revRbr2, respectively, and 50 M H2O2 for FdpA. Arrows indicate the time points of the successive additions
of NROR, Rd-D, revRbrs or FdpA, and H2O2. Black and gray curves represent the reaction in the presence or absence of revRbrs or FdpA, respectively. Red curves
correspond to the part with all the products added. The H2O2-reductase activity rates (s1) resulted from the subtraction of the experimental slope (M/s) before
and after the addition (represented in a different color) of the substrate, H2O2, divided by the protein concentration (M).
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difficile physiological electron donors of these proteins are still unknown and its
genome does not encode any Rd that could act as a redox partner, as happens in a few
organisms, we used a heterologous system to perform the assays. We found that the
truncated Rd domain (Rd-D) of E. coli FDP (flavoRd) and its reductase, homologous to
NADH:Rd oxidoreductases (NROR), were able to reduce FdpA and the two revRbrs in
the presence of NADH (see Fig. S4, insets).
To test the H2O2-reductase activity, we spectrophotometrically measured the NADH
consumption upon addition of H2O2 to a premix containing NADH, NROR, Rd-D, and
either FdpA, revRbr1, or revRbr2. A clear H2O2-reductase activity was observed for
revRbr1 and revRbr2 with rates of 2.1  0.1 s1 and 7.7  0.7 s1, respectively (Fig. 3A
and B; Table 1). The reduced activity detected for revRbr1 might be related to its lower
content of iron compared to revRbr2. In contrast, we detected only a negligible
H2O2-reductase activity with a rate of 0.27  0.03 s1 for FdpA (Fig. 3C and Table 1). It
should be mentioned that thus far such activity was reported only for the FdpF from C.
difficile (35).
The O2-reductase activity was measured by following O2 consumption using an O2
Clark-type selective electrode. FdpA, revRbr1, or revRbr2 were added to an air-saturated
buffer (260 M O2) containing both NROR and Rd-D from E. coli and an excess of NADH
(5 mM). We observed an O2-reductase activity for FdpA, revRbr1, and revRbr2 with rates of
1.4  0.3 s1, 1.2  0.1 s1, and 2.0  0.4 s1, respectively (Fig. 4 and Table 1). These
activities may be underestimated since the physiological partners in C. difficile were not
used in the assays as they remain to be identified. However, we can conclude from these
results that FdpA acts as an NADH-linked O2-reductase and that the two revRbrs act both
TABLE 1 NADH linked H2O2- and O2-reductase activities of FDPs and revRbrsa
Gene Name
Avg activity  SD (s1)
NADH:H2O2-reductase NADH:O2-reductase NADH:NO-reductase
CD1157 FdpA 0.27  0.03 1.4  0.3 0.16  0.07
CD1474 revRbr1 2.1  0.1 1.2  0.1
CD1524 revRbr2 7.7  0.7 2.0  0.4
aNADH-linked H2O2 and NADH-linked O2 reductase activities were determined in the presence of NADH, Rd-
D and NROR for FdpA, revRbr1, and revRbr2. The concentration of NADH used was 200 M for the H2O2-
reductase activity and 5 mM for the O2-reductase and the NO-reductase activities. For H2O2-reductase
activity, the rates were calculated subtracting the experimental slope (M/s) before and after the addition
of H2O2, divided by the protein concentration (M). For O2-reductase activity, the rates were calculated
subtracting the experimental slope (M/s) before and after the addition of each enzyme, divided by its
concentration (M). For NO-reductase activity, the calculated rates were calculated subtracting the
experimental slope (M/s) before and after the addition of FdpA, divided by its concentration (M). The
data are averages of the calculated rates of five experiments (H2O2-reductase), six experiments (O2-
reductase), and six experiments (NO-reductase) with the standard deviations.
FIG 4 O2-reductase activity of revRbr1, revRbr2 and FdpA. At least six assays for each enzyme were performed using a Clark-type electrode
selective for O2. The data presented are representative of the results obtained. Each assay contained 5 mM NADH as electron donor, and protein
concentrations were 2.5 M for NROR and Rd-D, 0.1 M for both revRbr1 (A) and revRbr2 (B), and 1 M for FdpA (C). Arrows indicate the time
points of successive additions of NADH, NROR, Rd-D and revRbr1, revRbr2 or FdpA. The O2-reductase activity rates (s1) measured in air-saturated
buffer (ca. 260 M O2) resulted from the subtraction of the experimental slope (M/s) before and after the addition (represented in red) of each
enzyme, divided by its concentration (M of enzyme).
Oxygen Detoxification in Clostridioides difficile ®












































as NADH-linked H2O2-reductase and NADH-linked O2-reductase in vitro. Furthermore, FdpA
exhibits a negligible NO reductase activity, 10-fold lower than for O2 reduction (see
Fig. S6A). Thus, like FdpF, FdpA is selective for O2.
Involvement of revRbrs and FDPs in H2O2 stress management. To study the
physiological role of the two revRbrs and the two FDPs in C. difficile, we deleted the
genes encoding revRbr1, revRbr2, and FdpF using the allelic chromosomic exchange
(ACE). We generated ΔrevRbr1, ΔrevRbr2, and ΔfdpF single mutants and a ΔrevRbr1/2
double mutant, as well as a ΔrevRbr1/2-ΔfdpF triple mutant. We also inactivated fdpA by
insertion of an intron into this gene using the clostron system to generate a fdpA single
mutant, a fdpA-ΔfdpF double mutant, a ΔrevRbr1/2-fdpA triple mutant, and a ΔrevRbr1/
2-ΔfdpF-fdpA quadruple mutant. Since we showed that revRbr1 and revRbr2, as well as
FdpF (35), have significant in vitro H2O2-reductase activities (Table 1), we first tested the
possible involvement of these proteins in C. difficile H2O2 resistance. Using disk diffu-
sion assays, we did not observe any difference in the growth inhibition area for the
	revRbr1/2, the 	revRbr1/2-	fdpF, and the ΔrevRbr1/2-ΔfdpF-fdpA mutants compared to
the WT strain in the presence of H2O2 (see Fig. S6B). These results suggest either that
these H2O2-reductase activities have no physiological role in the detoxification of H2O2
in C. difficile or that the existence of other enzymes scavenging H2O2 prevents to
observe a phenotype in our conditions.
Involvement of revRbrs and FDPs in C. difficile low O2 tolerance. Since both
revRbrs and both FDPs act as NADH dependent O2-reductases (Table 1), we assessed
the ability of the different mutants to tolerate low O2 tensions. For this purpose, we
incubated tryptone-yeast extract (TY) plates spotted with serial dilutions of each strain
in anaerobiosis or in the presence of different low O2 tensions (0.1 or 0.4%). No
difference in growth between the WT strain and the mutants was observed in anaer-
obiosis (Fig. 5). Similarly, we did not detect any growth defect for the ΔrevRbr1,
ΔrevRbr2, and ΔfdpF single mutants compared to the WT strain when exposed to O2
FIG 5 Role of revRbrs and FDPs in low O2 tension tolerance. Serial dilutions of the 630Δerm, the different mutants, and the
complemented strains were spotted on TY taurocholate plates. Plates were then incubated 64 h either in anaerobic atmosphere
(control) or in the presence of 0.1 or 0.4% O2. These pictures are representative of four and three independent experiments for
the mutant and complemented strains, respectively (see also Fig. S7 and S8). (A) Role of revRbrs in low O2 tension tolerance; (B)
role of FDPs in low O2 tension tolerance; (C) additive O2-reductase activities of FDPs and revRbrs.
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tensions up to 0.4% (Fig. 5A and B). In contrast, there was a growth defect for the fdpA
mutant under these conditions, whereas no differences were observed in the presence
of lower O2 tensions (i.e., 0.1 and 0.2%) (Fig. 5B; see also Fig. S7A). We were not able to
complement this reduced O2 tolerance by expressing fdpA on a plasmid either from its
own promoter (both A and B dependent promoters in pMTL84121 plasmid) or from
an anhydrotetracycline (aTc)-inducible promoter (Ptet) (pDIA6103 plasmid) (see
Fig. S7B). Of note, overexpression of fdpA in the presence of 100 ng ml1 of aTc resulted
in a growth defect even in anaerobiosis, suggesting that the overexpression of fdpA is
toxic for C. difficile. On the other hand, the growth defect observed for the fdpA mutant
in the presence of 0.4% O2 was restored when the fdpA disrupted by the clostron
insertion was replaced by a wild-type copy of fdpA using the ACE technique (Fig. 5B).
In addition, we observed the same growth defect for a ΔfdpA mutant generated by ACE
in the presence of 0.4% O2 (see Fig. S7B). Altogether, these results indicate that FdpA
plays a role in low O2 tolerance in C. difficile. Strikingly, deletion of both revRbr-
encoding genes strongly affected the growth compared to each single mutant and the
WT strain in the presence of 0.1 or 0.4% O2 (Fig. 5A). The growth of this double mutant
was fully restored when we expressed either the revRbr1 or the revRbr2 gene under the
control of their own promoter, indicating a functional redundancy between both
revRbrs in their ability to reduce O2 and confirming a crucial role of revRbrs in O2
tolerance in C. difficile. In contrast to revRbrs, the inactivation of both FDP-encoding
genes only resulted in a slight but reproducible decreased O2 tolerance compared to
the fdpA single mutant at 0.4% (Fig. 5B; see also Fig. S7C). In addition, the introduction
of pMTL84121-PB-fdpF did not increase the growth of the fdpA-ΔfdpF mutant, indi-
cating that FdpF cannot replace FdpA to restore O2 tolerance at 0.4% (Fig. 5B).
To determine whether the O2-reductase activities of both FDPs and revRbrs could be
additive, we exposed the ΔrevRbr1/2-ΔfdpF and the ΔrevRbr1/2-fdpA triple mutants, as
well as the quadruple mutant, to low O2 tensions. Inactivation of fdpF did not decrease
the O2 tolerance of the ΔrevRbr1/2 double mutant whatever the O2 tension tested
(Fig. 5C; see also Fig. S8). Interestingly, inactivation of fdpA increased the O2 tolerance
of the ΔrevRbr1/2 double mutant when exposed to 0.1% but not 0.4% O2. This effect
was FdpF dependent since the quadruple mutant (ΔrevRbr1/2-	fdpF-fdpA::erm) was less
tolerant than the ΔrevRbr1/2 double mutant and both triple mutants to O2 from
concentrations as low as 0.1% (Fig. 5C; see also Fig. S8). Remarkably, we noticed that
the introduction of pMTL84121-PB-fdpF restored the O2 tolerance observed in the
ΔrevRbr1/2-fdpA::erm triple mutant in the presence of 0.1% O2, confirming the role of
FdpF in O2 tolerance at extremely low O2 tension (Fig. 5C). In addition, at 0.4% O2, no
colony was observed for the quadruple mutant while both triple mutants were able to
grow when they were non-diluted (Fig. 5C; see also Fig. S8). From these results, we
conclude that O2-reductase activities of both FDPs and revRbrs are additive, and we
propose that FdpF plays a minor but visible role in O2 tolerance under these conditions.
Altogether, these results demonstrate the role of both revRbrs and FDPs in O2 tolerance
mechanisms in C. difficile.
DISCUSSION
In the present study, we identified two revRbrs and two FDPs as the O2-reductases
in C. difficile. We showed that these enzymes are important for O2 tolerance of this
bacterium and that their activities are additive. Indeed, a quadruple mutant inactivated
for all genes encoding these proteins has a strong growth defect at 0.1% O2 and is
unable to grow in the presence of 0.4% O2. This demonstrates for the first time the
physiological role of these two classes of enzymes in the ability of a strict anaerobe to
tolerate low physiological O2 tensions (
0.5%). It is worth noting that O2 tolerance
varies among the different C. difficile ribotypes. Indeed, whereas the survival of R20291
(ribotype 027) or 5235 (ribotype 078) vegetative cells sharply decreases after 3 h of air
exposure, vegetative cells of 630Δerm strain (ribotype 012) are still detectable after 24
h (54). Moreover, the R20291 strain has a decreased O2 tolerance compared to the
630Δerm strain in the presence of 0.1 and 0.4% O2 (17). However, in both 630Δerm and
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R20291 backgrounds, this low O2 tolerance process depends on the alternative sigma
factor involved in general stress response, B, which is involved in transcription of fdpA,
fdpF, revRbr1, and revRbr2 (17; this study). Accordingly, both revRbr- and FDP-encoding
genes harbor a B-consensus sequence in their promoter, and the phenotype of the
quadruple mutant at low O2 tension phenocopies that of the sigB mutant. However,
while the transcription of fdpF, revRbr1, or revRbr2 appears to be strictly B dependent
(Fig. 1) (39), fdpA is transcribed from two promoters depending on A and B. Of note,
the expression of fdpA, fdpF, revRbr1, or revRbr2 is not induced by amoxicillin and
clindamycin exposure, two antibiotics known to promote CDI through the disruption of
a healthy microbiota that results in an increased O2 level in the gut (see below) (55). On
the other hand, the expression of these genes is upregulated upon brief aeration of C.
difficile, whereas no induction is observed after a short exposure to 5% O2 or when
grown in microaerophilic conditions (2% O2) (15, 55, 56). These discrepancies could be
linked to the differences in stress exposure conditions. Further studies are required to
elucidate the exact role of air or low O2 exposure on the expression of genes encoding
revRbrs and FDPs and whether this effect is mediated by B. Interestingly, homologs of
revRbr1/2 (Rbr3A/B) and of two class A FDPs (FprA1/2) are present in C. acetobutylicum,
and the expression of the corresponding genes is induced upon 5% O2 flushing (21, 57,
58). In this bacterium lacking B, the expression of rbr3A/B and fprA1/2 is negatively
controlled by the PerR repressor (59, 60), and a perR mutant has increased O2 con-
sumption, aerotolerance, and ROS resistance (60). In C. difficile, a PerR-encoding gene
cluster is present. This cluster contains genes encoding a canonical rubrerythrin
(CD0825) and a desulfoferrodoxin (CD0827) (a superoxide reductase) that are homologs
to PerR targets in C. acetobutylicum (59). Using the consensus defined in C. acetobuty-
licum, we failed to identify an identical PerR box in the promoter region of fdp and
revRbr genes but also upstream the CD0825 operon. The role of PerR in the physiology
of C. difficile and in the control of fdp and revRbr genes remains to be studied.
We also demonstrated that both purified revRbrs reduce O2 and H2O2 into H2O,
although H2O2 is the preferred substrate, as observed for revRbrs in C. acetobutylicum
(20). On the other hand, FdpA only acts as NADH-linked O2-reductase in vitro. Although
some FDPs have been shown to scavenge both NO and O2 (32, 45), FdpA and FdpF lack
this dual activity (see Fig. S8) (35). In C. acetobutylicum, O2-reductase activity of class A
FDPs FprA1/2 are 100 times greater than those of Rbr3A/B (20, 21). In our conditions,
O2-reductase activities of both revRbrs and FdpA are rather similar and 10-fold lower
than the one described for FdpF (between 1.2 and 2 s1 compared to 16 s1) (35).
However, in FdpF, all the domains involved in the electron transfer from NADH to O2 are
present, while revRbrs and FdpA need intermediate proteins to perform such a transfer.
Since the natural electron transfer proteins associated with revRbrs and FdpA remain
unknown in C. difficile, our assays were performed with Rd-D and NROR from E. coli that
most probably result in a lower O2-reductase activity. Therefore, the activities determined
in these experimental conditions may be considerably underestimated. C. difficile 630 has
no genes encoding Rds, as also observed in many organisms having FDPs and in which the
electron donors of these enzymes remain also to be determined (24).
Even if the enzymatic properties of revRbrs and FDPs from several microorganisms
have been characterized, less is known about their physiological role, especially in the
ability of anaerobes to deal with O2 (24, 61). In C. difficile, the relative importance of
both revRbrs and FDPs in O2 tolerance seems to be variable. Indeed, only the fdpA
single mutant showed a reduced O2 tolerance, while we need to inactivate both
revRbrs-encoding genes to observe a growth defect in the presence of low O2 tensions.
This clearly indicates a functional redundancy of revRbrs sharing both a high level of
similarity and a common control of their production by B. On the other hand, the
double mutant ΔrevRbr1/2 showed a strongly reduced tolerance to 0.1% O2, highlight-
ing the crucial role of these proteins in the growth of C. difficile at very low O2 tensions.
Surprisingly, fdpA inactivation in the ΔrevRbr1/2 mutant increased the tolerance at 0.1%
O2. Although the underlying mechanism responsible for this higher tolerance is not
characterized, this effect is dependent on FdpF, since its inactivation completely abolished
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the growth whatever the O2 concentration tested (Fig. 5). Further investigations are needed
concerning the expression or the activity of FdpF in different genetic backgrounds and
oxygenation conditions. While the two revRbrs and FdpF also harbor significant H2O2-
reductase activities in vitro (35), inactivation of these genes does not result in increased
H2O2 sensitivity, strongly suggesting that other enzymes efficiently scavenging H2O2 are
present in C. difficile. Three catalases and a peroxidase (CotE) are present in C. difficile but
only produced during sporulation (33, 62). However, a secreted glutamate dehydrogenase
has been shown to participate in resistance to H2O2 (63). In addition, other proteins such
as a canonical Rbr (CD0825) and a bacterioferritin comigratory protein (CD1822), that are
homologs to proteins with peroxidase activity in other organisms (61) might contribute to
protect C. difficile vegetative cells from H2O2 stress. Further work is needed to characterize
all the pathways involved in H2O2 protection and to demonstrate the possible physiological
role of the revRbrs and FdpF in H2O2 detoxification.
Previous studies have shown that NO-specific FDPs play a role in the protection of
bacteria from NO-related killing within macrophages (64, 65). However, no studies have
linked O2-specific FDPs and revRbrs with virulence or colonization. Several recent
studies demonstrate that antibiotic administration, a CDI risk factor, increased the O2
level within the gut by modifying the microbiota. Indeed, antibiotherapy notably
depletes clostridia that produce butyrate, a compound directly consumed by entero-
cytes through O2 conversion to CO2 (14, 66). Moreover, some vegetative cells have
been found associated with the mucus (67–69), a place in which the O2 level is higher
than in the lumen (11, 70). Thus, C. difficile vegetative cells cope with O2 tensions during
the colonization process and, in such nonstrict anaerobic environments, the ability to
tolerate small amounts of O2 appears to be essential (55). Accordingly, both sigB and
iscS2 mutants, affected in their ability to tolerate low O2 tensions, have been shown to
be impaired in colonization in axenic mice (16, 17). Since both revRbrs and FDPs play
a crucial role in C. difficile low O2 tolerance, further studies are needed to show that
these proteins are important during the colonization process.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The C. difficile strains and plasmids used in this study are
listed in Table S1 in the supplemental material. C. difficile strains were grown anaerobically (5% H2, 5%
CO2, 90% N2) in TY (Bacto tryptone, 30 g liter1, yeast extract, 20 g liter1 [pH 7.4]), in Pep-M (71), or in
C. difficile minimal medium (CDMM) (72). For solid media, agar was added to a final concentration of 17
g liter1. When necessary, cefoxitin (Cfx; 25 g ml1), thiamphenicol (Tm; 15 g ml1), or erythromycin
(Erm; 2.5 g ml1) were added to C. difficile cultures. E. coli strains were grown in LB broth or in M9
minimal medium supplemented with FeSO4 to a final concentration of 200 M. When indicated,
ampicillin (100 g ml1), chloramphenicol (15 g ml1), or kanamycin (50 g ml1) was added to the
culture medium.
Construction of C. difficile strains. The clostron gene knockout system (73, 74) was used to
inactivate the fdpA (CD1157) gene, yielding the insertional mutant strain 630Δerm fdpA::erm (CDIP588).
We designed primers to retarget the group II intron of pMTL007-CE5 to insert it into the fdpA gene in
sense orientation after nucleotide 225 in the coding sequence (see Table S1). The PCR product generated
by overlap extension was cloned between the HindIII and BsrG1 sites of pMTL007-CE5 to obtain
pDIA6374. C. difficile transconjugants obtained with E. coli HB101(RP4) containing pDIA6374 were
selected on brain heart infusion (BHI) agar containing Tm and Cfx and then plated on BHI agar containing
Erm. PCRs on transconjugants chromosomal DNA were performed to verify the integration of the intron
into the fdpA gene and the splicing of the group I intron from the group II intron after integration.
The ΔrevRbr1 (ΔCD1474), ΔrevRbr2 (ΔCD1524), ΔfdpA (ΔCD1157), and ΔfdpF (ΔCD1623) knockout
mutants were obtained using the codA-mediated allele exchange method (75, 76). Then, 1.5-kb frag-
ments located up- and downstream of these genes were PCR amplified from 630Δerm genomic DNA
using the pairs IMV917/NK70 and NK71/IMV918, IMV919/NK64 and NK65/IMV920, CF80/CF81 and
NK180/CF83, and IMV914/NK58 and NK59/IMV915 (Table S1B) for ΔrevRbr1, ΔrevRbr2, ΔfdpA, and ΔfdpF,
respectively. Purified PCR fragments were then introduced into the pMTLSC7315 plasmid using a Gibson
Assembly master mix (Biolabs). The sequences of the resulting plasmids were verified by sequencing. The
plasmids obtained introduced in HB101(RP4) E. coli strain were transferred by conjugation into the C.
difficile 630Δerm strain. Transconjugants were selected on BHI plates supplemented with Tm and C.
difficile selective supplement (SR0096; Oxoid). Isolation of faster growing single-crossover integrants was
performed by serial restreaking on BHI plates containing Cfx and Tm. Single-crossover integrants were
then restreaked on CDMM plates supplemented with fluorocytosine (50 g ml1), allowing the isolation
of double-crossover events. After confirmation of plasmid loss (Tm-sensitive clones), the presence of the
expected deletion in clones was checked by PCR. Steps were repeated in each different mutant in order
to generate C. difficile multi mutants (see Table S1A).
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Complementation of the different mutants. To complement revRbr1, revRbr2, and fdpF, the
promoter region and the open reading frame of the corresponding gene were amplified by PCR using
oligonucleotide pairs CF115/CF116, CF113/CF114, and IMV699/IMV700, respectively. The PCR products
were cloned into pMTL84121 to produce pDIA6538, pDIA6537, and pDIA6388 (see Table S1A). For fdpA,
the region encompassing both A- and B-dependent promoters and the open reading frame was
amplified by NK259/NK260 and inserted by Gibson Assembly into pMTL84121 amplified by inverse PCR
with NK261/NK262 to yield pDIA6870. To express fdpA under the control of the inducible Ptet promoter,
the open reading frame was amplified by PCR using oligonucleotides IMV978 and IMV979. The PCR
product was cloned into pDIA6103 (37) to produce pDIA6806. E. coli HB101(RP4) strain containing each
plasmid was mated with single or double mutants (see Table S1). To complement the fdpA mutant at the
same locus, the clostron was removed by the chromosomal introduction of a fdpA wild-type copy using
ACE. First, a PCR fragment encompassing fdpA and 1.5-kb fragments located upstream and downstream
of fdpA gene was amplified from 630Δerm genomic DNA using primers CF80/CF83. This fragment was
then introduced into pMTLSC7315 by Gibson Assembly, yielding pDIA6956. The resulting plasmid was
transferred from E. coli HB101(RP4) to the fdpA::erm mutant by mating. Selection of transconjugants,
isolation of faster growing single-crossover integrants, and isolation of double-crossover events were
performed as described above. After confirmation of plasmid loss, the presence of the fdpA gene in lieu
of the intron was checked by PCR.
Oxygen and H2O2 stress tolerance assays. For O2 tolerance assays, 5 l of different serial dilutions
(from 100 to 105) of C. difficile strains grown for 7 h in TY were spotted on TY plates containing 0.05%
taurocholate. Plates were then incubated in the presence of different O2 tensions or in anaerobiosis in
a microaerophilic workstation from Baker Ruskinn. When needed, aTc was added to the plate to induce
fdpA expression. The last dilution allowing growth was recorded after incubation at 37°C for 64 h. Disk
diffusion assays were conducted as follows. Cultures of C. difficile strains grown in Pep-M medium were
plated on calibrated Pep-M agar. A sterile 6-mm paper disk was placed on the agar surface, and 4 l of
1 M hydrogen peroxide (H2O2) was added to the disk. The diameter of the growth inhibition area was
measured after 24 h of incubation at 37°C.
Transcriptional SNAPCd fusions. To construct transcriptional fusions, we used pFT47, a plasmid
containing the SNAPCd gene (38). A fragment containing either the complete promoter region of fdpA
(positions 308 to 114 from the start codon) or only the B-dependent promoter region (104 to
114) was amplified using genomic DNA and the primer pairs IMV949/IMV950 and IMV976/IMV950,
respectively. The DNA fragments were inserted between the EcoRI and XhoI sites of pFT47 to obtain
pDIA6517 and PDIA6669, respectively. To construct the revRbr2- or fdpF-transcriptional SNAPCd fusion,
the promoter region (190 to 30 or 202 to 14 from the TSS) was amplified using genomic DNA and
primer pairs CF23/CF24 or CF21/CF22, respectively. The DNA fragments were inserted into pFT47
between the EcoRI and XhoI sites to obtain pDIA6459 and pDIA6458. The plasmids introduced into E. coli
HB101(RP4) were then transferred by conjugation into C. difficile 630Δerm strain and the sigB mutant (see
Table S1).
Fluorescence microscopy and image analysis. To monitor the expression of the different tran-
scriptional fusions, the strains were grown for 16 h in BHI. SNAP labeling and fluorescence microscopy
were performed as previously described (38). The images were taken with exposure times of 200 ms for
autofluorescence and 500 ms for SNAP. Cells were observed on a Nikon Eclipse TI-E microscope 60
objective and captured with a CoolSNAP HQ2 Camera. For quantification of the SNAP-TMR Star signal
resulting from transcriptional fusions, the pixel intensity was measured and corrected by subtracting the
average pixel intensity of the background. Images were analyzed using ImageJ.
Protein production, purification, and quaternary structure determination. The coding region of
revRbr1 and revRbr2 were PCR amplified using genomic DNA and primer pairs IMV970/IMV971 or
IMV968/IMV969 to produce a 540-bp PCR product that was cloned into pET20 (Novagen), yielding
pDIA6635 or pDIA6671. The amino acid sequence of FdpA was used to synthesize its encoding gene
(GenScript, Inc., USA) using codon optimized for expression in E. coli, which was cloned into a pET24a
plasmid. After verification by sequencing, the plasmids were introduced in E. coli BL21(DE3)Gold. Strains
overexpressing revRbr1, revRbr2, or fdpA were grown aerobically at 37°C at 150 rpm in M9 minimal
medium, with 20 mM glucose, 0.1 mM FeSO4, and ampicillin (for revRbr1 and revRbr2) or kanamycin (for
fdpA). When the optical density at 600 nm reached 0.4, 0.1 mM FeSO4 was added, and gene expression
was induced by 1 mM IPTG (isopropyl--D-thiogalactopyranoside) for both revRbrs and 0.1 mM IPTG for
fdpA. After 6 h of growth at 30°C, the cells were harvested by centrifugation, resuspended in a buffer
containing 50 mM Tris-HCl (pH 7.5), and stored at –20°C. Cells were disrupted by at least three cycles in
a French press apparatus at 16,000 lb/in2 (Thermo) in the presence of DNase (Applichem). The crude
extract was cleared by low-speed centrifugation at 25,000  g for 25 min and then at 138,000  g for
90 min at 4°C to remove cell debris and the membrane fraction, respectively. The soluble extract was
dialyzed overnight at 4°C against buffer A (20 mM Tris-HCl [pH 7.5], 18% glycerol) and subsequently
loaded onto a Q-Sepharose Fast Flow column (65 ml; GE Healthcare) previously equilibrated with buffer
A. Proteins were eluted with a linear gradient from buffer A to buffer B (buffer A containing 500 mM
NaCl). The eluted fractions were monitored throughout the purification process by SDS-PAGE and
UV-visible spectroscopy. Fractions containing the desired protein were pooled and concentrated. For
both revRbrs, the concentrated fraction was then loaded onto a size exclusion Superdex S75 column
(330 ml; GE Healthcare) equilibrated with buffer A containing 150 mM NaCl. The fractions containing the
protein were pooled and concentrated. For revRbr1, the last fraction was loaded onto a Fractogel column
(20 ml; Merck Millipore) previously equilibrated with buffer A and eluted with a linear gradient from
buffer A to buffer B. After purification, FdpA was incubated overnight at 4°C in the presence of 1 mM FMN
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and subsequently applied to a PD-10 desalting column to eliminate unbounded FMN. Fractions con-
taining purified proteins were verified by SDS-PAGE (see Fig. S3A).
The quaternary structures of the proteins were determined by size exclusion chromatography.
Proteins were loaded onto a 25-ml Superdex S200 10/300 GL column (GE Healthcare) previously
equilibrated with buffer A containing 150 mM NaCl. A mixture containing tyroglobulin (669 kDa),
apoferritin (443 kDa), -amylase (200 kDa), alcohol dehydrogenase (150 kDa), albumin (66 kDa), carbonic
anhydrase (29 kDa), and dextran blue (2000 kDa) as a void volume marker was used as the standard (see
Fig. S3B).
Protein, metal, and flavin quantification. Purified protein samples were quantified using a bicin-
choninic acid kit (Thermo) and bovine serum albumin as the standard. The iron content was determined
by the phenanthroline colorimetric method. Protein samples were incubated for 15 min with 1 M HCl and
for further 30 min with 10% trichloroacetic acid at room temperature, centrifuged at 5,000  g for
20 min, and neutralized by the addition of 15% ammonium acetate. Samples were then incubated with
10% hydroxylamine and 0.3% 1-10-phenantrhroline. The absorbance spectrum was measured, and the
iron content was quantified by using 510  11.2 mM1 cm1. The flavin type and content were
determined as previously described (35).
Spectroscopic methods. UV-visible spectra were obtained in a Perkin-Elmer Lambda 35 spectro-
photometer. Electron paramagnetic resonance (EPR) spectroscopy was performed using a Bruker EMX
spectrometer equipped with an Oxford Instruments ESR-900 continuous-flow helium cryostat and a
high-sensitivity perpendicular mode rectangular cavity. Protein samples were prepared aerobically to
final concentrations of 1 mM (FdpA and revRbr2) or 600 M (revRbr1). Partially reduced samples were
also prepared anaerobically by incubation with 1 equivalent of menadiol.
Redox titrations. The reduction potentials of the FMN from FdpA and of the Rd domain from the
revRbrs were determined by redox titrations monitored by visible absorption spectroscopy in a Shimadzu
UV-1603 spectrophotometer. Protein samples at a 30 M final concentration in buffer C (50 mM Tris-HCl
[pH 7.5] and 18% glycerol) were titrated inside an anaerobic chamber (Coy Lab Products) by stepwise
addition of a buffered sodium dithionite solution in the presence of a mixture of redox mediators (0.5 M
each): N,N-dimethyl-p-phenylenediamine (E=°  340 mV), 1,2 naphtoquinone-4-sulfonic acid (E=° 
215 mV), 1,2 naphtoquinone (E=°  180 mV), trimethylhidroquinone (E=°  115 mV), phenazine
methosulfate (E=°  80 mV), 1, 4 naphtoquinone (E=°  60 mV), phenazine ethosulfate (E=°  55
mV), 5-hydroxy-1,4-naphtoquinone (E=°  30 mV), duroquinone (E=°  5mV), menadione (E=°  0
mV), plumbagin (E=°  – 40 mV), resorufin (E=°  –51 mV), indigo trisulfonate (E=°  –70 mV), indigo
disulfonate (E=°  –110 mV), phenazine (E=°  –125 mV), 2,5-hydroxy-p-benzoquinone (E=°  –130 mV),
2-hydroxy-1,4-naphtoquinone (E=°  –152 mV), anthraquinone-2-sulfonate (E=°  –225 mV), phenosa-
franine (E=°  –255 mV), safranine (E=°  –280 mV), and neutral Red (E=°  –325 mV). A combined Pt
electrode (Ag/AgCl in 3.5 M KCl, as a reference) was used and calibrated at 23°C against a saturated
quinhydrone solution (pH 7). The reduction potentials are reported in relation to the standard hydrogen
electrode. The reduction potentials determined for revRbrs and FdpA were calculated by adjusting a
Nernst equation to the experimental data obtained by UV-visible spectroscopy. In all cases, the reduction
potential of the diiron sites could not be determined since they have very low molar absorptivities. For
the revRbrs, the absorption values obtained at 490 nm (typical of the oxidized Rd-like site) were
normalized in relation to the full oxidized protein, and a theoretical curve of the oxidized population was
fitted using a SciLab routine and applying a Nernst equation for a one-electron transfer process. The
populations were calculated as follows:
E  E0  RT lnQ ,

















where R  8.314 J K1 mol1, T  298.15 K, n  1 electron, and F  96485 C mol1.
The theoretical model and curve adjustment were performed using Scilab 6.0.2. The E0 for the
rubredoxin center of the two revRbrs was determined from the fit. For FdpA, the FMN moiety is the only
contributor for the visible spectrum and undergoes two consecutive redox reactions. The reduction
potentials were determined as for the revRbrs, using the appropriate Nernst equation for two sequential
monoelectronic processes and taking into consideration the molar absorptions of the oxidized and
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Therefore, the experimental data measured at 450 nm were normalized and fitted considering the
contribution of both the oxidized and the semireduced (semiquinone [SQ]) forms of FMN multiplied by the
























and where R  8.314 JK1 mol1, T  298.15 K, n  1 electron, and F  96485 C mol1.
As before, the theoretical model and curve adjustment were performed using Scilab 6.0.2. The E01
and E02 were determined from the fit.
Spectrophotometric measurement of the H2O2-reductase activity. Because the physiological
electron donor to the C. difficile revRbrs and FdpA is unknown, we used an artificial electron-donating
system: a mixture of the Rd domain (Rd-D) of the E. coli FDP (flavoRd) and of the flavoRd reductase
(NROR, gene ID 947088, E. coli strain K-12). The E. coli proteins were overexpressed and purified as
previously described (50). The enzymatic activity for H2O2 was determined by UV-visible spectroscopy,
inside an anaerobic chamber (Coy Lab Products). The assays were performed in buffer C. The reaction
was monitored at 340 nm, determining the NADH consumption (340  6,220 mM1 cm1). A mixture of
buffer containing 200 M NADH, NROR (2.5 or 5 M for the revRbrs or FdpA assays, respectively), and
Rd-D (2.5 or 5 M for revRbrs or FdpA assays, respectively) was used. Different amounts of NROR and
Rd-D were tested and optimized in combination with each enzyme in order to ensure that the reaction
rates were maximized. The reaction was initiated by the addition of H2O2. Concentrations of revRbr1,
revRbr2, or FdpA were 0.1, 0.03, and 1 M, respectively. Different amounts of H2O2 were used for each
of the three enzymes to evaluate the dependence of the rates with the amount of substrate. No
significant differences were verified within the range of concentrations used (10 to 150 M). This
indicates that, if these enzymes follow a Michalis-Menten behavior, the Km value is low and therefore not
covered by the range used. This also indicates that all the assays are in Vmax conditions. The calculated
rates (s1) presented in Table 1 were calculated subtracting the experimental slope (M s1) before and
after the addition of H2O2, divided by the protein concentration (M).
Measurement of O2-reductase activity. The O2-reductase activity of the proteins was measured
amperometrically with a Clark-type electrode selective for O2 (Oxygraph-2K; Oroboros Instruments,
Innsbruck, Austria). The assays were performed in buffer C. The O2-reductase activity was evaluated at
25°C in air equilibrated buffer (260 M O2) in the presence of 5 mM NADH, NROR (2.5 M), and Rd-D
(2.5 M). Different amounts of NROR and Rd-D were tested and optimized in combination with each
enzyme in order to ensure that the reaction rates were maximized. The reaction was initiated by addition
of revRbr2 (0.1 M), revRbr1 (0.1 M), or FdpA (1 M). Assays were performed in the presence of catalase
(640 nM). The calculated rates (s–1) presented in Table 1 were calculated subtracting the experimental
slope (M s1) before and after the addition of each enzyme, divided by the protein concentration (M).
Measurement of NO-reductase activity. The NO-reductase activity of FdpA was measured ampero-
metrically with a Clark-type electrode selective for NO (ISO-NOP; World Precision Instruments, Sarasota,
FL). The assays were performed in buffer C. The NO-reductase activity was evaluated at 25°C in degassed
buffer in the presence of an O2-scavenging system (10 mM glucose, 375 nM glucose oxidase, and 750 nM
catalase), NROR (2.5 M), and Rd-D (2.5 M). Sequential additions of NO (up to 12 M) were followed by
the addition of 5 mM NADH, and the reaction was initiated by the addition of FdpA (0.1 M). Stock
solutions of 1.91 mM NO were prepared by saturating a degassed buffer C in a rubber seal-capped flask
with pure NO gas (Air Liquide) at 1 atm on ice: gaseous NO was flushed through a 5 mM NaOH trap to
remove higher N-oxides, and a second trap with deionized water to remove aerosols. After this, the
solution was allowed to equilibrate at room temperature.
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